Angiotech Pharmaceuticals, Inc. - Notice of conference call and webcast - Second quarter 2007 financial results
18 Juli 2007 - 9:00PM
PR Newswire (US)
VANCOUVER, July 18 /PRNewswire-FirstCall/ -- Angiotech
Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), a global
specialty pharmaceutical and medical device company, will host a
conference call discussing its financial results for the second
quarter ended June 30, 2007. Thursday, August 2, 2007 at 11:00 AM
(ET) (8:00 AM Pacific, 9:00 AM Mountain, 10:00 AM Central) Dial
information is as follows: North America (toll-free): (866)
578-5788 International: (617) 213-8057 Enter passcode: 78719252 A
live webcast will be available to all interested parties through
Angiotech's website at http://www.angiotech.com/ under the
Investors Relations section. A press release announcing Angiotech's
financial results will be issued prior to the conference call at
approximately 10:00 AM ET (7:00 AM Pacific, 8:00 AM Mountain, 9:00
AM Central). A replay archive of the conference call will be
available until August 9, 2007. Replay archive information is as
follows: North America: (888) 286-8010 International: (617)
801-6888 Enter passcode: 92205136 About Angiotech Pharmaceuticals
Angiotech Pharmaceuticals, Inc. is a global specialty
pharmaceutical and medical device company with over 1,500 dedicated
employees. Angiotech discovers, develops and markets innovative
treatment solutions for diseases or complications associated with
medical device implants, surgical interventions and acute injury.
To find out more about Angiotech (NASDAQ:ANPINASDAQ:TSXNASDAQ:ANP)
please visit our website at http://www.angiotech.com/. CONTACT:
Deirdre Neary, Manager, Investor Relations and Corporate
Communications, Angiotech Pharmaceuticals, Inc., (604) 222-7056, ;
Jodi Regts, Manager, Investor Relations and Corporate
Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930,
DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Deirdre Neary,
Manager, Investor Relations and Corporate Communications, Angiotech
Pharmaceuticals, Inc., (604) 222-7056, ; Jodi Regts, Manager,
Investor Relations and Corporate Communications, Angiotech
Pharmaceuticals, Inc., (604) 221-7930,
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel